Citigroup Maintains Buy on Dow, Lowers Price Target to $35
Citigroup Maintains Buy on Dow, Lowers Price Target to $35
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Citigroup Maintains Buy on Dow, Lowers Price Target to $35
Bitcoin's 4-Year Cycle Remains Intact, 21Shares Says: This Is The 2026 Price Target
Intel Shares Rise Over 3% After Key Trading Signal
'Intel-Backed AI Chip Firm SambaNova to Quintuple Valuation to $10 Billion' - The Information
JP Morgan Raises Quarterly Dividend From $1.50 To $1.65/Share
JPMorgan Chase Announces $50B Buyback Plan, Effective July 1
Goldman Sachs Plans To Raise Quarterly Dividend From $4.50 To $5.00/Share, Pending Board Approval
Fed Announces Large U.S. Banks Well Positioned To Withstand Recession After Stress Test Results
JPMorgan Raises Dividend, Announces $50B Buyback, Shares Rise
President Trump Says Exxon, Chevron Among Companies Being Investigated As Part Of Gail Prices Surge
Shares of semiconductor and chip stocks are trading higher after Micron Technology reported strong Q3 financial results. Also, the industry may be rallying alongside Qualcomm after…
The FDA approved Unknown Drug from MICRO LABS under application ANDA217238 on 2026-06-24.
Aurobindo Pharma gained approval for its ANDA208746 on June 24, 2026, introducing a generic version of the brand-name drug icosapent ethyl to the market. This regulatory clearance …
Green Dot and CommerceOne shareholders voted overwhelmingly to approve the pending strategic acquisition. This milestone brings the transaction significantly closer to expected com…
EagleRock Land announced the filing of its Q1 2026 10-Q after completing its IPO. The company reports robust liquidity over $200 million and no outstanding debt, supporting aggress…
Institutional holdings report (13F-HR) filed by 13F-HR/A - Redwood Investment Management, LLC (0001717479) (Filer).
The company granted Restricted Stock Units under its 2021 Equity Incentive Plan. These awards compensate employees and align their interests with shareholders.
The company's counsel issued an opinion letter regarding the sale of up to $6.27 million in common stock. This regulatory validation supports the planned capital raise and ensures …
CIM Opportunity Zone Fund entered into a financing agreement with lenders including Wells Fargo and Truist for the Westlands Grape project, involving construction and bridge loans.
Tango Therapeutics appointed Robert Azelby to its Board of Directors. His oncology commercialization expertise is viewed as a strategic asset as the company advances its pipeline.